95 related articles for article (PubMed ID: 6543401)
1. [Effect of various doses of naloxone on circulating corticosterone levels in the rat].
Montilla P; Torrecillas F; Varo A; Muñoz MC
Rev Esp Fisiol; 1984 Dec; 40(4):401-4. PubMed ID: 6543401
[TBL] [Abstract][Full Text] [Related]
2. [Effect of oxytocin and naloxone on the plasma levels of corticosterone in the rat].
Montilla P; Muñoz JL; Ríos JE; Muñoz MC
Rev Esp Fisiol; 1989 Dec; 45(4):319-22. PubMed ID: 2631154
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
[TBL] [Abstract][Full Text] [Related]
4. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
Alcaraz C; Vargas ML; Fuente T; Milanés MV
J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
[TBL] [Abstract][Full Text] [Related]
5. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats.
Seale JV; Wood SA; Atkinson HC; Harbuz MS; Lightman SL
J Neuroendocrinol; 2004 Dec; 16(12):989-98. PubMed ID: 15667454
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
7. Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats.
Korányi L; Endröczi E
Acta Physiol Hung; 1983; 62(1):75-83. PubMed ID: 6650196
[TBL] [Abstract][Full Text] [Related]
8. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
[TBL] [Abstract][Full Text] [Related]
9. Diurnal alteration in opiate effects on the hypothalamo-pituitary-adrenal axis: changes in the mechanism of action.
Kiem DT; Fekete MI; Makara GB
Eur J Pharmacol; 1995 Jan; 272(2-3):145-50. PubMed ID: 7713158
[TBL] [Abstract][Full Text] [Related]
10. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
Cicero TJ; Nock B; O'Connor L
J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
[TBL] [Abstract][Full Text] [Related]
11. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
12. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
Leggett JD; Jessop DS; Fulford AJ
Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
[TBL] [Abstract][Full Text] [Related]
13. Effect of naloxone on central adrenergic stimulation of corticosterone secretion.
Gadek-Michalska A; Turoń M; Bugajski J
Folia Med Cracov; 1997; 38(3-4):37-45. PubMed ID: 10481380
[TBL] [Abstract][Full Text] [Related]
14. Influence of cyclooxygenase inhibitors on the central histaminergic stimulations of hypothalamic - pituitary - adrenal axis.
Bugajski AJ; Thor P; Głód R; Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2003 Dec; 54(4):643-52. PubMed ID: 14726617
[TBL] [Abstract][Full Text] [Related]
15. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
16. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
17. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
Finn DP; Hudson AL; Kinoshita H; Coventry TL; Jessop DS; Nutt DJ; Harbuz MS
J Psychopharmacol; 2004 Mar; 18(1):47-53. PubMed ID: 15107184
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
19. The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat.
Morano MI; Vázquez DM; Akil H
Mol Cell Neurosci; 1994 Oct; 5(5):400-12. PubMed ID: 7820364
[TBL] [Abstract][Full Text] [Related]
20. Effect of aging on 24-hour pattern of stress hormones and leptin in rats.
Cano P; Cardinali DP; Spinedi E; Esquifino AI
Life Sci; 2008 Jul; 83(3-4):142-8. PubMed ID: 18593590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
